Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Paracrine signals of the tumour niche control the growth of tumours, either directly or by modulation of an anti-tumour immune response. Several of these paracrine factors are produced as membrane-bound proteins and need to be released by limited proteolysis.
Members of the a disintegrin and metalloprotease (ADAM) family of transmembrane proteases are major mediators of cytokine and growth factor release. I will discuss the potential role of ADAM proteases in shaping a tumour permissive niche. I will provide evidence that within the tumour micro-environment the family member ADAM17 is a major promoter of primary tumour growth and metastasis through initiation of TNF-mediated necroptosis, the release of EGF receptor ligands and the induction of IL-6/GP130 trans-signalling. In this context I will discuss the controversial role of IL-6 family cytokines in the control of tumour growth. By using a novel mouse model of cell-autonomous IL-6/GP130 signalling, I will provide evidence that this might be linked to cell type-specific signalling of these cytokines. Based on our findings I will discuss potential novel therapeutic strategies.
